Patient Selection
Between June 2010 and October 2016, a total of 76 patients with primary
cervical carcinomas were treated at Sichuan Cancer Hospital with IMRT
boast based on ICBT after concurrent chemoradiotherapy. All patients had
a large high risk clinical target volume (HR-CTV) volume
(>40cc) at the time of brachytherapy, excluding patient
with adequate coverage of HR- CTV by optimized ICBT. excluding patient
with adequate coverage of HR- CTV by optimized ICBT.
The analysis of the data was performed in October 2020 with a median
patient follow up of 85 months (range 47.9-124.2) and a median patient
age of 48.9±8.3 years. The initial loco-regional staging included
clinical examination under local anesthesia, chest and abdominopelvic
computed tomography (CT) and pelvic magnetic resonance imaging (MRI).
Positron Emission Tomograpy/Computed Tomography (PET/CT) was not done.
The disease was staged according to the 2009 International Federation of
Gynecology and Obstetrics (FIGO) classification. Patients with distant
metastases (except para-aortic lymph nodes) were excluded from this
treatment. All included patients were treated with curative intent. The
clinic-pathological features of
the patients are given in Table 1.